Aidapak Recalls Pioglitazone Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling 15 mg Pioglitazone tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The hazard is a labeling error (label mixup) without reported injuries, fitting the Moderate severity criteria for minor labeling errors or low-risk contamination.
Plain-English summary
Aidapak Services, LLC is recalling 90-count bottles of Pioglitazone 15 mg tablets (NDC 00591320530) due to a potential labeling error. The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The recall involves specific pedigree codes AD22845_1, AD25452_10, and AD28322_4, all with an expiration date of 4/30/2014.
The recall was initiated because the Pioglitazone tablets may have been mislabeled as Lactase Enzyme 3000 units, Phosphorus 250 mg, or Aripiprazole 15 mg. This label mixup could lead to patients receiving the wrong medication.
Patients and consumers who have these specific Pioglitazone tablets should stop using them and contact their healthcare provider or pharmacist for instructions on how to return the product or obtain a replacement.
The recalled product
- Product
- PIOGLITAZONE, Tablet, 15 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591320530.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 90
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- PIOGLITAZONE
- Tablet
- 15 mg has the following codes: Pedigree: AD22845_1
- EXP: 4/30/2014
- Pedigree: AD25452_10
- Pedigree: AD28322_4
- EXP: 4/30/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02